Diabetes Drug Linked to Lower Risk of Heart Disease

Diabetes Drug Linked to Lower Risk of Heart Disease

London: Using liraglutide – an injectable drug widely used to lower blood sugar levels - may help reduce risk of myocardial infarction, stroke or cardiovascular death, suggests a study. Liraglutide – a diabetes medication in clinical use since 2009 – is a glucagon-like peptide 1 receptor agonist that lowers blood sugar and reduces body weight. The findings showed that people who used liraglutide had five fewer major cardiovascular events for three years.

“Our study provides support for the cardiovascular effectiveness of liraglutide among a broader unselected group of patients, providing important confirmatory evidence from routine clinical practice,” said Bjorn Pasternak, senior researcher at the Department of Medicine, Karolinska Institutet in Sweden. “We believe it may be of interest to drug regulators, clinical guidelines, physicians and patients,” Pasternak added. Use of liraglutide was also associated with reduced risk of cardiovascular death and any cause of death. (IANS)

Top Headlines

No stories found.
Sentinel Assam
www.sentinelassam.com